Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Aprecap Capsule
Manufacturer/Marketed By : Glenmark Pharmaceuticals Ltd
$12.42 $3.81
Aprecap capsules, containing 125 mg of aprepitant and 80 mg of its active component, belong to the neurokinin-1 antagonist class, designed to combat nausea and vomiting associated with chemotherapy. Suitable...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Aprepitant 125 mg + Aprepitant 80 mg
Active Pharmaceutical Ingredient
Aprecap Capsule
12,42$
3,81$
Aprecap capsules, containing 125 mg of aprepitant and 80 mg of its active component, belong to the neurokinin-1 antagonist class, designed to combat nausea and vomiting associated with chemotherapy. Suitable for adults and adolescents aged 12 and above, Aprecap is often prescribed alongside other medications to effectively prevent nausea induced by potent chemotherapy agents such as cisplatin, cyclophosphamide, doxorubicin, and epirubicin. By blocking specific receptors in the brain, Aprecap plays a crucial role in managing the side effects of cancer treatments, ensuring patients maintain a better quality of life during their therapy. However, it is important to note that Aprecap is contraindicated for individuals with known allergies to any of its components. For those seeking relief from chemotherapy-induced nausea, Aprecap offers a reliable solution that aligns with comprehensive cancer care. Always consult with a healthcare provider before starting Aprecap to ensure it is appropriate for your specific medical situation. With its proven efficacy, Aprecap capsules are an essential part of supportive cancer therapy.
Active Pharmaceutical Ingredient
Uses
• Aprecap capsule is primarily utilized for managing chemotherapy-induced nausea and vomiting (CINV), a frequent complication associated with cancer treatments. Patients undergoing chemotherapy often experience significant discomfort from nausea and vomiting. The use of Aprecap capsule can help alleviate these symptoms, improving the overall quality of life during treatment. By effectively reducing these side effects, Aprecap supports patients in their cancer journey.
• In addition to its role in CINV management, Aprecap capsule may be prescribed to prevent nausea and vomiting associated with specific chemotherapy regimens. Certain chemotherapy drugs are more likely to induce severe nausea, making proactive treatment essential. Aprecap capsule can be administered before chemotherapy sessions to help mitigate these anticipated side effects. This preventive approach allows patients to focus on their treatment rather than the distress of nausea.
• Aprecap capsule is also beneficial for patients who have previously experienced significant nausea and vomiting from chemotherapy. For those individuals, the fear of recurrence can be daunting, and effective management is crucial. The use of Aprecap capsule in subsequent treatments helps to instill confidence in patients, knowing that measures are in place to manage potential side effects. This assurance can positively impact their willingness to continue necessary cancer therapies.
• Furthermore, Aprecap capsule can be a vital component of a comprehensive antiemetic regimen during cancer treatment. It is often used in combination with other medications to enhance overall effectiveness against nausea and vomiting. By integrating Aprecap capsule into a patient’s treatment plan, healthcare providers can offer a more robust defense against these debilitating side effects. This multifaceted approach contributes to better adherence to chemotherapy protocols and improved patient satisfaction.
Benefits
Anti-nausea Drug Aprecap blocks the effects of chemicals in your body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused by certain medicines or cancer treatments. This Aprecap Capsule helps you recover better from cancer treatments such as radiation therapy or chemotherapy.
Side Effects
Like all medication, Aprecap Capsule may cause some side effects. If you experience any of these side effects,, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Dizziness
• Weakness
• Tiredness
• Diarrhoea
• Constipation
• Heartburn
• Epigastric pain
Common Side Effects
• Allergic skin reaction
• Severe Itching
• Difficulty in breathing
• Difficulty in swallowing
• Bloating of abdomen
• Stomach pain
• Hiccups
How To Use
Aprepitant 125 mg + 80 mg can be taken with or without food, but it is recommended to take it at the same time each day for the best results. The dosage and frequency of administration may vary depending on the individual's condition and medical history. Your doctor will monitor the patient's response to the drug and adjust the dose as needed.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Aprecap Capsule. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Aprepitant 125 mg + 80 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Anti-nausea Drug Aprecap is safe to use in patients with kidney disease. No dose adjustment of Aprecap Capsule is recommended. If you experience any side effects, please consult your doctor.
• Breastfeeding: It is not recommended to breastfeed while taking Aprecap Capsule. Aprecap 125 mg Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Aprecap Capsule, talking to your doctor about the possible risks and benefits of continuing to breastfeed is essential. Your doctor can help you make the best decision for you and your baby's health.
• Liver: Aprepitant 125 mg + 80 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Aprecap Capsule and report any unusual symptoms or changes in liver function to their doctor. The dose of Anti-nausea Drug Aprecap may need to be adjusted in patients with liver disease.
• Pregnancy: There are no adequate and well-controlled studies on pregnant women. Aprecap Capsule should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus.
• Driving: Aprecap Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Aprecap Capsule.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.